Cargando…
Depletion of cyclic‐GMP levels and inhibition of cGMP‐dependent protein kinase activate p21(Cip1)/p27(Kip1) pathways and lead to renal fibrosis and dysfunction
Cell‐cycle regulatory proteins (p21(Cip1)/p27(Kip1)) inhibit cyclin and cyclin‐dependent kinase (CDK) complex that promotes fibrosis and hypertrophy. The present study examined the role of CDK blockers, p21(Cip1)/p27(Kip1) in the progression of renal fibrosis and dysfunction using Npr1 (encoding gua...
Autores principales: | Das, Subhankar, Neelamegam, Kandasamy, Peters, Whitney N., Periyasamy, Ramu, Pandey, Kailash N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7540536/ https://www.ncbi.nlm.nih.gov/pubmed/32686172 http://dx.doi.org/10.1096/fj.202000754R |
Ejemplares similares
-
FRET-based cyclic GMP biosensors measure low cGMP concentrations in cardiomyocytes and neurons
por: Calamera, Gaia, et al.
Publicado: (2019) -
Inhibition of PDE5A1 guanosine cyclic monophosphate (cGMP) hydrolysing activity by sildenafil analogues that inhibit cellular cGMP efflux
por: Subbotina, Anna, et al.
Publicado: (2017) -
NO/cGMP signalling in platelets
por: Schinner, Elisabeth, et al.
Publicado: (2009) -
cGMP and cardiac hypertrophy
por: Perera, Ruwan K, et al.
Publicado: (2015) -
Analysis of cGMP signalling with transgenic mice expressing FRET-based cGMP sensors
por: Wen, Lai, et al.
Publicado: (2013)